Epsilon M&A Deal Report - Rhön Klinikum Portfolio of 40 Hospitals

Transaction Multiples for the Valuation of Private Companies

Fresenius SE & Co. KGaA > Rhön Klinikum Portfolio of 40 Hospitals

Announced Date : 13 September 2013

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Fresenius SE & Co. KGaA

Target: Rhön Klinikum Portfolio of 40 Hospitals

Target Country: Germany

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Operates 40 hospitals with a total of approximately 11,302 beds as well as 13 outpatient facili ...

No EMAT : 65867

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating ***

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1245

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
10/07/2014	Vithas Sanidad	Xanit Group	Spain	**
19/08/2014	Recipharm	Corvette Group Pharmaceutical Services	Italy	***

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database